Interventional device developer Medtronic has received the CE Mark for its Advisa and Ensura SR SureScan single-chamber pacemaker devices.
Both pacemakers have been approved for MR scans positioned on any region of the body, according to the firm. Advisa and Ensura SR feature improved diagnostic information and storage, as well as a 35% improvement in battery longevity when compared with the company's Adapta single-chamber pacing system, Medtronic said.
The new systems include an Advisa or Ensura SR MRI device with any SureScan-labeled lead, which must be used together to be considered MR-conditional, Medtronic said.
